OptimizeRx Corp Annual Nonoperating Income (Expense) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
OptimizeRx Corp annual/quarterly Nonoperating Income (Expense) history and growth rate from 2013 to 2024.
  • OptimizeRx Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$1.38M, a 300% decline year-over-year.
  • OptimizeRx Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$5.09M.
  • OptimizeRx Corp annual Nonoperating Income (Expense) for 2024 was -$5.68M.
  • OptimizeRx Corp annual Nonoperating Income (Expense) for 2023 was $1.24M, a 45.3% increase from 2022.
  • OptimizeRx Corp annual Nonoperating Income (Expense) for 2022 was $852K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$5.68M* -$6.92M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $1.24M +$386K +45.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $852K Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2018 $46.2K +$20.3K +78.2% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-12
2017 $25.9K -$16.4K -38.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 $42.3K +$40K +1766% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $2.27K +$1.33K +142% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 $935 +$689 +280% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $246 Jan 1, 2013 Dec 31, 2013 10-K 2015-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.